Last updated on 17 Sept 2024
Owner Info
Lennham Pharmaceuticals, Inc.
53 Main Street, Suite 206
Concord MA 01742, UNITED STATES OF AMERICA
Serial Number
2463332 filed on 14 Mar 2024
Correspondent
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue,
Boston MA 02210-2206,
UNITED STATES OF AMERICA
2463332
NA
NA
WORD
14 Sept 2023
US
Status Date | Action Taken |
---|---|
17th Sept 2024 | International Registration in Australia Protected correspondence sent |
16th Sept 2024 | IP Right Registration Published |
16th Sept 2024 | Status change to Registered/Protected |
9th Jul 2024 | Application Accepted correspondence sent |
8th Jul 2024 | IP Right has been Examined |
8th Jul 2024 | IP Right Acceptance Published |
8th Jul 2024 | Status change to Accepted |
4th Jul 2024 | Examination expedited |
4th Jul 2024 | Awaiting examination |
4th Jul 2024 | IP Right Filed Published |